Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 February 2021 Photo UFS photo archive
The National Control Laboratory for Biological Products (NCL) Building.

There can be no compromise when it comes to the quality of medicines made available to the public.

The UFS-based National Control Laboratory for Biological Products (NCL) is a full member of the international WHO-National Control Laboratory Network for Biologicals and one of 12 laboratories worldwide contracted to perform vaccine testing for the World Health Organisation (WHO). The NCL is also the only vaccine-testing laboratory in the country that performs the final quality-control testing of all human vaccine batches marketed in South Africa on behalf of the South African Health Products Regulatory Authority (SAHPRA).

In its role as a vaccine-testing laboratory for the WHO, the NCL helps to ensure that the vaccines purchased through the WHO prequalification programme for international distribution to resource-limited countries, meet the high standards of quality, safety, and efficiency. 

International testing standards

The laboratory received the status of a pharmaceutical testing laboratory after the South African Accreditation System (SANAS) endorsed its quality-management systems as of a high standard according to the International Standards Organisation’s requirements.

With its international testing standards, the NCL must ensure that all its operations – from the way documents are compiled and stored, to the maintenance of equipment and infrastructure, as well as staff competency – are performed according to international guidelines.

The laboratory has all the quality systems in place to ensure high-quality test results. The certificate of Good Manufacturing Compliance received in 2019 indicates that laboratory testing is on the expected level for any pharmaceutical testing laboratory and manufacturer. This certification is very strict and means that the NCL complies with exceptionally strict standards for pharmaceutical labs anywhere in the world. The certification offers the South African Health Products Regulatory Authority, the WHO, and other national control laboratories around the world the confidence that the test results from the NCL can be trusted.

Licensed as pharmaceutical manufacturer

The laboratory is also licensed as a pharmaceutical manufacturer. Although the lab does not manufacture, it needs to comply with manufacturing standards. It is rare for a pharmaceutical testing laboratory (such as the NCL) outside of a manufacturing context to qualify for both certifications.

News Archive

Early diagnosis of hearing loss is important
2017-09-11

  Description: Magteld small Tags: birth defects, hearing loss, Dr Magteld Smith, Department of Otorhinolaryngology

Dr Magteld Smith, lecturer in the
Department of Otorhinolaryngology
at the University of the Free State (UFS)
Photo: Supplied


One of the most common, misunderstood and neglected birth defects in developing countries is hearing loss, which can most severely impair and have a dramatic impact of the quality of life the of the person with hearing loss. 

This is according to Dr Magteld Smith, lecturer in the Department of Otorhinolaryngology at the University of the Free State (UFS). 

“Hearing loss refers to all the different types and levels of hearing loss, from slight to profound hearing loss,” she said. 

Derived from a number of retrospective studies in South Africa, it was found 17 people a day are born with hearing loss. More than 95% of those children are born to hearing parents. This estimate excludes children and adults who lost their hearing after birth. 

According to Dr Smith, hearing loss strikes at the very essence of being human, because it hinders communication with others. To enable people to communicate with those with hearing loss, the university’s Department of South African Sign Language teaches students sign language. This year, the department enrolled 230 students. A number of these students are from the Faculty of Education. These students could from 2017 for the first time choose sign language as a subject.

“Studies have shown that important language skills are learned before the age of three because hearing and learning language are closely tied together. Brain development of the auditory pathways and language cortex is occurring in young children as they respond to auditory and visual language. In families that are part of deaf culture, these parents automatically sign from day one, so the baby is learning visual (sign) language, and the appropriate brain development is occurring.

Beskrywing: Doof readmore Sleutelwoorde: geboorte-afwykings, gehoorverlies, dr Magteld Smith, Departement Otorinolaringologie

About 230 students are enrolled for the subject, South African 
Sign Language, at the UFS. As an assignment some of the students 
were asked to design posters to create deaf awareness among 
others on campus. From the left are: Poleliso Mpahane, 
Masajin Koalepe, Ntshitsa Mosase, and Zoleka Ncamane. 
Photo: Leonie Bolleurs

“However, if a child has an undiagnosed hearing loss and the parents are unaware, the child will not receive the needed language stimulation — and the hoped-for development won’t take place. It is critical to understand that children with hearing loss have their own talents, different levels of intelligence, socioeconomic circumstances and different abilities, just like hearing children. Therefore, one size does not fit all,” Dr Smith said. 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept